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Abstract
In an effort to reduce the complications related to
invasive ventilation, the use of noninvasive ventilation
(NIV) has increased over the last years in patients with
acute respiratory failure. However, failure rates for NIV
remain high in specific patient categories. Several
studies have identified factors that contribute to NIV
failure, including low experience of the medical team
and patient–ventilator asynchrony. An important
difference between invasive ventilation and NIV is the
role of the upper airway. During invasive ventilation
the endotracheal tube bypasses the upper airway, but
during NIV upper airway patency may play a role in
the successful application of NIV. In response to
positive pressure, upper airway patency may decrease
and therefore impair minute ventilation. This paper
aims to discuss the effect of positive pressure
ventilation on upper airway patency and its possible
clinical implications, and to stimulate research in this
field.
Introduction
Noninvasive ventilation (NIV) is increasingly used in
acute respiratory failure, for instance in patients with ex-
acerbation of chronic obstructive pulmonary disease or
acute heart failure [1-3]. An important goal of NIV is to
prevent endotracheal intubation and thereby reduce the
complications related to invasive ventilation [1,4]. How-
ever, failure rates of NIV range between 5 and 50% [5,6]
and most of these patients require endotracheal intu-
bation [5-9]. Several factors have been identified that in-
crease the success rate of NIV. These factors include
careful selection of patients, properly timed intervention,
a comfortable and well-fitting interface, coaching and
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encouragement of patients, careful monitoring, and a
skilled and motivated team [6,8,10]. In particular, careful
selection is of major importance in patients with chronic
obstructive pulmonary disease. A low pH (<7.25) is a
strong predictor of NIV failure [10,11], but an improve-
ment in pH 1 to 2 hours after the initiation of NIV
accurately predicts NIV success [5,11-13].
Today, the pathophysiology of NIV failure is incom-
pletely understood. How can ventilation be inadequate
with NIV, but adequate with similar levels of support
after endotracheal intubation? An important difference
in the application of NIV versus invasive ventilation is,
evidently, the involvement of the upper airway. During
invasive ventilation the endotracheal tube bypasses the
upper airway and the cuff of the endotracheal tube pro-
vides an air-tight seal in the trachea. In contrast, during
NIV the upper airway might play a role in the efficiency
of delivered ventilation. Indeed, ventilator settings du-
ring NIV affect the patency of the upper airway [14,15].
This effect implies that deviant behavior of the upper
airway may play a role in the failure of NIV. The present
concise review discusses the physiology and current un-
derstanding on the effects of NIV on upper airway pa-
tency. We will discuss the clinical relevance of the
available studies and will list important points to stimu-
late research in this field.
Noninvasive ventilation and upper airway
physiology
Patient–ventilator asynchrony
The aim of NIV is to decrease the work of breathing
and/or improve oxygenation and ventilation. The most
frequently used mode of NIV is pressure support venti-
lation (PSV). For the most effective unloading of the
inspiratory muscles, the ventilator should cycle in syn-
chrony with the patient’s neural respiratory drive [16].
Although triggering and cycling of mechanical support
during PSV depends on the patient’s respiratory effort,
asynchrony between the patient and ventilator occurs
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frequently [17]. Several types of asynchrony and dys-
synchrony between the patient’s neural drive and venti-
lator support have been identified and are shown in
Figure 1 [18,19]. Suboptimal synchrony between the pa-
tient and the ventilator may be affected by respiratory
mechanics, the breathing pattern, neural drive, ventilator
settings, the type of interface and the amount of air leak
[18,20-23]. The consequences of patient–ventilator
asynchrony are poorly understood, but a high incidence
of asynchrony is associated with discomfort and a
prolonged duration of NIV [17].
The above-discussed types of asynchrony are related
to the interaction between the activity of the inspiratory
muscles and the ventilator’s response. Indeed, this is suf-
ficient for patients requiring invasive ventilation. How-
ever, during NIV it is also important that the ventilator
acts in synchrony with the upper airway muscles. Glottic
narrowing during inspiration increases upper airway re-
sistance and may limit effective ventilation. We will
discuss this type of asynchrony after briefly summari-
zing the knowledge of upper airway physiology relevant
to the topic of this review.
Upper airway
The upper airway comprises the nose, oral cavity, pha-
rynx and larynx. The upper airway is involved in che-
wing, swallowing, speech and smell, and its primary
functions are to act as a conductor of air, to humidify
and warm the inspired air and prevent foreign materials
from entering the tracheobronchial tree [24]. The nose
and oral cavity are mainly static in their conducting
function, whereas the pharynx and larynx predominantly
are muscular structures and thus may alter the patency
of the upper airway [15,25]. A simplified representation
of the muscles of the upper airway is shown in Figure 2
and a view of the intrinsic muscles of the larynx shown
in Figure 3 [26,27].
Stella and England studied the effect of pressure and
flow in isolated piglet upper airway [28]. They showed
that the presence of negative pressure in the upper air-
way and flow during inspiration results in phasic respira-
tory activity of the posterior cricoarytenoid muscle
above tonic levels, which results in glottic widening du-
ring inspiration and reduces resistance to airflow. This
response effectively unloads the inspiratory muscles.
Positive pressure and flow during expiration results in
phasic activity of the thyroarytenoid muscle, resulting in
glottic narrowing and therefore increased resistance to
the expiratory flow. Accordingly, this study shows that,
at least in an animal model, respiratory flow patterns
affect the activity of the upper airway muscles.
Earlier, Sant’Ambrogio and colleagues showed that flow
receptors actually respond to temperature changes from
body to room temperature (thermoreceptors) [29]. Stella
and England used these findings to analyze the laryngeal
muscle response to continuous versus oscillating flow
patterns and different body and room temperatures. They
reported that a negative pressure and inspiratory flow re-
sults in increased posterior cricoarytenoid activity (opening
of the glottis), independent of the stimulus modality. Fur-
thermore, positive pressure and expiratory flow increased
the thyroarytenoid activity for all stimuli, although constant
room air applied to the upper airway results in more activ-
ity of the thyroarytenoid muscle than an oscillatory stimu-
lus, implying that constant room air results in enhanced
constriction of the glottis. Accordingly, both pressure and
flow receptors play an important role in muscle activity of
the upper airway during respiration [28,30].
Figure 1 Screenshots from a ventilator in noninvasive ventilation pressure support mode. Tracings from top to bottom: airway pressure
(Paw), airway flow (V’), tidal volume (V), and diaphragm electrical activity (Edi). Different types of patient ventilator asynchrony and dyssynchrony
are shown: double triggering, early cycling off, trigger delay, wasted efforts and auto triggering [18,19].
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Receptors in the upper and lower airway modulate ac-
tivity of the upper airway muscles. The most prominent
receptors are the bronchopulmonary C-fiber receptors,
rapidly adapting receptors (RARs) and slowly adapting
pulmonary stretch receptors (PSRs) (Table 1).
Pulmonary C-fiber receptors are located between the
alveolar epithelium and the pulmonary capillaries,
whereas bronchial C-fiber receptors have been identified
in the conducting airway. The receptors’ fiber endings
extend into the space between epithelial cells or form
a plexus immediately under the basement membrane.
C-fiber receptors are excited by large mechanical deforma-
tions, chemical stimuli (for example, capsaicin and carbon
dioxide), lung edema by increased interstitial fluid volume,
or increased temperature [31,32]. C-fiber receptor acti-
vation evokes inhibitory effects (apnea or bradypnea;
hypotension and bradycardia). C-fiber receptor stimulation
can result in closing of the upper airway by glottic
narrowing to protect the respiratory system against in-
halation of gaseous irritants, by activation of laryngeal
muscles [33].
RARs are located in and under the epithelium
throughout the respiratory tract from the nose to the
bronchi. The receptors respond in reaction to mecha-
nical (extremely sensitive) and chemical stimuli, and
produce mainly excitatory effects such as tachypnea
[33,34]. The RARs in the larynx are usually called irri-
tant receptors because of their activation by inhaled irri-
tants such as ammonia or cigarette smoke, and they
probably cause cough and expiration reflexes. When the
laryngeal mucosa is stimulated, RAR reflexes elicit laryn-
goconstriction and bronchoconstriction, which may be
part of the glottal closure seen during cough. However,
the exact modulation of laryngeal upper airway muscle
activities by RARs is incompletely understood [31,33,34].
PSRs do not affect patency of the upper airway but
modulate the respiratory cycle: they terminate inspiration
and extend expiration [35]. PSRs are activated by stret-
ching the airway wall and fire throughout the respiratory
cycle (tonic activity) or in response to lung inflation
(phasic activity). The discharge rate is progressively in-
creased as a function of lung volume. PSRs are also widely
known as the receptors responsible for the Hering–Breuer
reflex, one of the first negative feedback loops in physi-
ology. Hering and Breuer found that lung inflation de-
creases the tidal volume and increases the respiratory rate,
thereby protecting the lungs from hyperinflation, while
maintaining constant alveolar ventilation: an inspiratory
off-switch [33,36].
To summarize, respiration and in particular patency of
the upper airway depends on a complex, but incom-
pletely understood, interplay between several inhibitory
Figure 3 Intrinsic muscles of the larynx. From [27].
Figure 2 Anatomical representation of the upper airway and
the important muscles controlling airway patency. From [26].
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and excitatory pathways. Physical conditions such as
pressure, flow and temperature affect upper airway pa-
tency. NIV may affect these physical characteristics and
therefore affect patency of the upper airway.
Interaction between the upper airway and
noninvasive ventilation
Moreau-Bussière and colleagues studied the effect of
NIV on activity of the glottal constrictor (thyroaryte-
noid) and dilator (cricothyroid) muscles in awake lambs.
Figure 4 shows thyroarytenoid, cricothyroid and dia-
phragm muscle activity during spontaneous breathing or
NIV with PSV [37]. During spontaneous breathing, both
the thyroarytenoid and cricothyroid muscles are active –
thyroarytenoid muscle activity occurring primarily at
the end of inspiration. However, with application of
pressure support during NIV, inspiratory cricothyroid
activity disappears whereas activity of the thyroarytenoid
muscle increases. This results in glottal narrowing and
restricted ventilation, as reflected by respiratory induc-
tance phlethysmography [37].
A subsequent study demonstrated that increased glot-
tal constrictor muscle activity during NIV depends
mainly on activation of bronchopulmonary receptors.
After bilateral vagotomy, the increase in inspiratory
activity of the thyroarytenoid muscle previously observed
with increasing support during NIV was absent [14].
There are limited data that demonstrate a similar re-
sponse to NIV in humans. Rodenstein and colleagues
exposed healthy subjects to increasing levels of support
with NIV while their glottis was continuously moni-
tored through a fiberoptic bronchoscope. The higher
the level of support, the narrower the glottic aperture
and the higher the airway resistance. This effect led to
Figure 4 Moving time averaged electrical activities of muscles during noninvasive ventilation. Moving time averaged electrical activities of
thyroarytenoid (TA), cricothyroid (CT), and diaphragm (Dia) muscles during noninvasive ventilation in wakefulness, without continuous positive
airway pressure (CPAP) and with pressure support ventilation, in newborn lambs [37]. i, inspiration; e, expiration.
Table 1 Relevant respiratory receptors and their location and effect
Receptors Location Stimulus Effect




stimuli and temperature increases
Inhibitory effects as apnea,
hypotension and bradycardia
Bronchial In the walls of conducting airway
Rapidly adapting In epithelium close to
bronchial venules
Very sensitive to mechanical
stimuli and slow response to
chemical stimuli
Irritant receptors cause cough
and expiration reflexes
Pulmonary stretch In close association with airway
smooth muscle
Mechanical changes, stretch of
airway wall
Terminate inspiration and extend
expiration (Hering–Breuer reflex).
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a progressive decrease in the percentage of tidal vol-
ume effectively reaching the lungs, apparently at least
partly due to the behavior of the glottis [15,38,39].
In summary, studies in animals and humans indicate
that positive pressure ventilation reduces patency of the
upper airway during neural inspiration.
Neurally adjusted ventilator assist (NAVA) is a rela-
tively new mode of noninvasive ventilatory support. The
key features of NAVA are that the ventilator is cycled by
diaphragm electrical activity, thereby improving patient–
ventilator synchrony [40,41], and that the level of
support is proportional to the electrical activity of the
diaphragm [42]. The electrical activity of the diaphragm
is measured by an array of bipolar electrodes mounted
on a nasogastric feeding tube.
In contrast to PSV, glottal constrictor muscle activity
does not increase with NAVA during inspiration in
lambs [43]. Apparently, NAVA induces less glottal clos-
ure and more synchronous ventilation and may thus be
advantageous compared with PSV during NIV. A pos-
sible underlying mechanism for the absence of glottal
constrictor activity during inspiration with NAVA is that
the pressure rise mimics the normal progressive recruit-
ment of the diaphragmatic motor units, whereas during
PSV insufflation from the ventilator is performed with a
constant level of pressure (decelerating flow pattern),
often with a short inspiratory rise time to further de-
crease the patient’s inspiratory work. The consequent
rapid nonphysiological rise in airway pressure at the on-
set of inspiration with PSV could be responsible for acti-
vating, in a reflex manner, the inspiratory activity of the
glottal constrictor muscles and thus limits the efficiency
of NIV [43]. This hypothesis should be the subject of
further clinical research.
Monitoring muscles of the upper airway
The importance of monitoring inspiratory muscle activ-
ity during mechanical ventilation has been stressed in
the literature [44]. In contrast, little is known about the
role of monitoring upper airway activity during NIV –
probably related to the complexity of monitoring the
upper airway function in these patients.
Activation of intrinsic laryngeal muscles affects glottis
opening and thus affects resistance to flow into and out
of the lungs [28]. Monitoring the recruitment of upper
airway dilator muscles during inspiration could be clinic-
ally relevant because the phasic activity of upper airway
dilator muscles increases with respiratory constraints, as
in patient–ventilator asynchrony [45,46]. Cheng and col-
leagues studied the upper airway in healthy subjects,
using magnetic resonance imaging with tagging [47].
This study showed not only that the genioglossus muscle
but also nonmuscular soft tissues surrounding the upper
airway move before the onset of inspiratory flow [47].
Movement of certain reference points on the genioglos-
sus muscle was greater during normal inspiration than
during loaded inspiration, suggesting that the increase in
activity of the muscle during loaded inspiration does not
result in dilation but in stiffening of the upper airway
[47]. Moreover, this study demonstrated that movement
of nonmuscular soft tissue affects upper airway patency.
A complex interaction exists between movement of
nonmuscular soft tissue and genioglossus muscle activ-
ity. Although laryngeal muscle (for example, genioglos-
sus or cricothyroid muscle) electromyography is feasible
during NIV [37,45], one should note that electromyog-
raphy does not provide information about nonmuscular
soft tissue movement. Additional techniques should
therefore be used to evaluate upper airway patency.
Magnetic resonance imaging probably provides the most
reliable information but it is expensive and cumbersome,
particularly in patients on NIV. Recently, a study showed
that the upper airway could be visualized with ultra-
sound, although the value of assessing upper airway pa-
tency with this technique has not been studied [48]. In
addition, endoscopy has been used to assess upper air-
way patency, but ideally should be used at different
levels in the upper airway.
Clinical relevance and future research
Increasing the success rate of NIV is of major clinical
importance. In contrast to invasive ventilation, the upper
airway plays an important role as a conductor of air dur-
ing NIV. Current literature suggests that during NIV it
is important that the ventilator acts in synchrony with
the upper airway muscles to allow adequate ventilation.
In lambs and piglets, the patency of the upper airway is
influenced by ventilator-induced changes in pressure
and flow [14,30,37,43]. However, we do not know
whether this phenomenon can be extrapolated to
humans. The involved reflexes are similar in humans to
those in newborn lambs, but are thought to be less
pronounced.
Today, there are limited data on the effects of NIV on
upper airway physiology in patients with acute respira-
tory failure. It is reasonable to assume that when the
ventilator cycles in synchrony with the upper airway, this
will improve efficiency of ventilation. As discussed,
upper airway patency is linked to neural respiratory
drive. Therefore, improved synchrony between the venti-
lator and respiratory drive may improve ventilation
partly by limiting wasted ventilation at the level of the
upper airway. Currently, it would be preliminary to pro-
vide recommendations on how the level of assist, level
of positive end-expiratory pressure and flow pattern
should be adapted to enhance patency of the upper air-
way in patients with acute respiratory failure.
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Future research should therefore aim at studying the
effect of different ventilator modes and settings on the
patency of the upper airway in patients. For example,
NAVA ventilation in lambs has been shown to decrease
glottal constrictor muscle activity compared with PSV
during NIV. Settings of the ventilator such as the rise
time, trigger sensitivity, and the level of pressure support
and positive end-expiratory pressure should also be the
subject of further research. These settings could influence
the behavior of the upper airway and potentially limit
adequate lung ventilation. Currently, a study is investigat-
ing the effect of ventilator settings during NIV on
upper airway patency in patients with an exacerbation of
chronic obstructive pulmonary disease (Clinicaltrials.gov
ID: NCT01791335). Our recommendations for further re-
search focus on inspiration, but expiration could also be
influenced by upper airway patency.
Conclusions
In conclusion, we have shown that regulation of the upper
airway is complex and influenced by NIV. The latter
findings are mostly based on animal data. Understanding
of the laryngeal reactions during different modes and set-
tings of NIV in patients will be crucial to determine
whether a diminished upper airway patency contributes to
NIV failure.
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